Link to this page

Your search term(s) "cyclic vomiting syndrome" returned 9 results.

Displaying all search results.

Appendix A: The Rome III Diagnostic Criteria for the Functional Gastrointestinal Disorders. IN: Drossman, D., ed. Understanding the Irritable Gut: The Functional Gastrointestinal Disorders. McLean, VA: Degnon Associates, Inc. 2008. pp 183-199.

This appendix is from a book that helps doctors and patients better understand functional gastrointestinal disorders (FGIDs), with text based on information developed by the Rome Foundation to identify, classify, and treat these disorders. This appendix presents the Rome criteria for the diagnoses of FGIDs; the criteria were developed by teams of experts to define patients for scientific study and help practicing doctors more precisely identify the disorders. The disorders covered include functional heartburn, functional chest pain of presumed esophageal origin, functional dysphagia, globus, functional dyspepsia, postprandial distress syndrome, epigastric pain syndrome, belching disorders, chronic idiopathic nausea, functional vomiting disorders, cyclic vomiting syndrome (CVS), rumination syndrome in adults, irritable bowel syndrome, functional bloating, functional constipation, functional diarrhea, functional abdominal pain syndrome (FAPS), functional gallbladder and Sphincter of Oddi disorders, functional fecal incontinence, functional anorectal pain, and functional defecation disorders. The diagnostic criteria for both childhood and adult FGIDs are included, although the remainder of the appendix only focuses on adult disorders. Readers are cautioned that the criteria are not meant for self-diagnosis and that a confident diagnosis can only be safely arrived at after a careful history and physical examination by a doctor. The diagnostic criteria are scheduled to be updated again in 2012.

Full Record   Printer Friendly Version

Cannabinoid Hyperemesis Syndrome: Cyclic Vomiting, Chronic Cannabis Use, and Compulsive Bathing. Practical Gastroenterology. 32(9): 79-80. September 2008.

This article describes cannabinoid hyperemesis syndrome, a disorder characterized by chronic marijuana use, cyclic vomiting, and compulsive bathing. The authors report the third case of this syndrome in the United States. The case involves a 19-year-old Hispanic man who presented to the emergency department with nausea and vomiting of 3 days duration, as well as daily marijuana use for the past 18 months. Symptoms include intractable nausea, nonbilious nonbloody vomiting 10 to 12 times per day, and epigastric pain. Nausea was relieved by hot showers and he reported taking up to 20 hot showers daily. This was his sixth hospital admission in the past 8 months, all for similar episodes. The authors report the diagnostic tests and supportive care given the patient and the subsequent diagnosis of hyperemesis syndrome. He was counseled to stop marijuana use and referred to a substance abuse program. Follow-up 5 months later demonstrated that he had abstained from marijuana use, has had no recurrent episodes of nausea or vomiting, and showers just once daily. The authors’ discussion focuses on the possible metabolic causes of this syndrome, as well as the need for more information about the role of cannabinoids in gastrointestinal motility. 9 references.

Full Record   Printer Friendly Version

Cyclic Vomiting Syndrome. Bethesda, MD: National Digestive Diseases Information Clearinghouse. 2008. 7 p.

This fact sheet describes cyclic vomiting syndrome (CVS), a condition characterized by episodes or cycles of severe nausea and vomiting that last for hours, or even days, which alternate with intervals with no symptoms. The fact sheet begins by describing CVS and its management, outlining the four phases of CVS: prodrome, episode, recovery, and symptom-free interval. The fact sheet reviews the triggers of CVS, symptoms, diagnosis, the relationship between CVS and migraine, treatment options, and complications. Many people can identify a condition or event that triggers an episode of nausea and vomiting. Infections and emotional stress are two common triggers. Vomiting can lead to severe dehydration that can be life-threatening. Symptoms of dehydration include thirst, decreased urination, paleness, exhaustion, and listlessness. Treatment varies by person, but people with CVS generally improve after learning to control their symptoms. They may be given medications that prevent a vomiting episode, stop an episode already in progress, speed up recovery, or relieve associated symptoms. Readers are referred to two resource organizations for more information: the Cyclic Vomiting Syndrome Association (www.cvasonline.org or 414–342–7880) and the National Organization for Rare Disorders (www.rarediseases.org or 800–999–6673). The fact sheet briefly describes the work of the National Digestive Diseases Information Clearinghouse, which provides information about digestive diseases to people with digestive disorders and to their families, health care professionals, and the public.

Full Record   Printer Friendly Version

North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Consensus Statement on the Diagnosis and Management of Cyclic Vomiting Syndrome. Journal of Pediatric Gastroenterology and Nutrition. 47: 379-393. 2008.

This article presents and discusses a consensus statement on the diagnosis and management of cyclic vomiting syndrome (CVS), a disorder noted for its intensity of vomiting, repeated emergency department visits and hospitalizations, and reduced quality of life. The consensus statement was created by a task force of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. The key issues addressed by the task force were the diagnostic criteria, the appropriate evaluation, the prophylactic therapy, and treatment of acute attacks. The recommended diagnostic approach is to use a strategy of targeted testing that varies with the presence of four “red flag” symptoms: abdominal signs such as bilious vomiting or tenderness, triggering events such as fasting or a high protein meal, abnormal neurological findings such as altered mental status or papilledema, and progressive worsening or a changing pattern of vomiting episodes. Treatment strategies include lifestyle changes, prophylactic drug therapy, and acute therapy including the use of 5-hydroxytryptamine receptor agonists as abortive therapy and 10 percent dextrose and ondansetron for those requiring intravenous hydration. Supportive care during acute episodes includes providing a less stimulating environment; replacement of fluids, electrolytes, and energy; use of antiemetics with or without sedation to lessen the nausea and vomiting; and provision of analgesia for pain. 1 figure. 8 tables. 84 references.

Full Record   Printer Friendly Version

Extreme Emesis: Cyclic Vomiting Syndrome. Practical Gastroenterology. 31(9): 21-26, 31-34. September 2007.

This article familiarizes readers with cyclic vomiting syndrome (CVS), a disorder of unknown cause that has been primarily identified in children but has also recently been diagnosed more often in adults. The authors note that acute episodes are typically misdiagnosed as gastroenteritis and food poisoning; this can lead to a 3- to 8-year delay in diagnosis. The authors help readers differentiate between the many organic causes of vomiting and CVS, a functional disorder without diagnostic tests and laboratory markers. The article reviews the clinical features of CVS, including differences between adults and children, potential pathophysiologic mechanisms, pertinent exclusionary investigations, and specific treatment approaches. Treatment can include recognition and avoidance of stressor or food triggers, prophylactic therapy, abortive therapy used to terminate breakthrough episodes, and supportive therapy for coping with an acute episode. Readers are referred to the Cyclic Vomiting Syndrome Association (www.cvsa.online), which offers a website, literature, electronic bulletins, and telephone and email support for patients and their families. 5 tables. 34 references.

Full Record   Printer Friendly Version

Childhood Functional Gastrointestinal Disorders: Child - Adolescent. IN: Drossman, D.A., ed. Rome III: The Functional Gastrointestinal Disorders. 3rd ed. McLean, VA: Degnon Associates, Inc. 2006. pp. 723-777.

This chapter on functional gastrointestinal disorders (FGIDs) in children and adolescents is from a lengthy reference book that presents the Rome III criteria for FGIDs, a classification system based on the assumption and premise that for each disorder there are identifiable symptom clusters that emerge across clinical and population groups. The authors of this chapter define childhood and adolescence as ranging from 4 to 18 years of age and note that some of the pediatric FGIDs, such as cyclic vomiting and functional abdominal pain, overlap in age presentation with the neonatal and toddler group. Disorders covered include adolescent rumination syndrome, cyclic vomiting syndrome, aerophagia, functional dyspepsia, irritable bowel syndrome (IBS), abdominal migraine, childhood functional abdominal pain, functional constipation, and nonretentive fecal incontinence. The chapter covers definitions, diagnostic criteria, reasons for changes from previous criteria, clinical evaluation, physiological factors, and treatment strategies for each of these disorders. The chapter concludes with a list of recommendations for future research in these disorders. 2 tables. 200 references.

Full Record   Printer Friendly Version

Childhood Functional Gastrointestinal Disorders: Neonate -Toddler. IN: Drossman, D.A., ed. Rome III: The Functional Gastrointestinal Disorders. 3rd ed. McLean, VA: Degnon Associates, Inc. 2006. pp. 687-722.

This chapter on childhood functional gastrointestinal disorders (FGIDs) is from a lengthy reference book that presents the Rome III criteria for FGIDs, a classification system based on the assumption and premise that for each disorder there are identifiable symptom clusters that emerge across clinical and population groups. The authors of this chapter focus on FGIDs in infants and toddlers, defining them as a variable combination of often age-dependent, chronic, or recurrent symptoms not explained by structural or biochemical abnormalities. The clinical expression of an FGID often depends on an individual's stage of development, particularly with regard to autonomic, affective, and intellectual development. Disorders covered include infant regurgitation, infant rumination syndrome, cyclic vomiting syndrome, infant colic, functional diarrhea, infant dyschezia, and functional constipation. The chapter covers definitions, diagnostic criteria, reasons for changes from previous criteria, clinical evaluation, physiological factors, and treatment strategies for each of these disorders. The authors stress that childhood FGIDs are not dangerous when the symptoms and parental concerns are addressed and contained. However, failed diagnosis and inappropriate treatments of functional symptoms may be the cause of needless physical and emotional suffering. In severe cases, well-meaning clinicians inadvertently co-create unnecessarily complex and costly solutions to functional symptoms, prolonging emotional stress and promoting disability. The chapter concludes with a list of recommendations for future research in these disorders. 7 figures. 6 tables. 134 references.

Full Record   Printer Friendly Version

Functional Gastroduodenal Disorders. IN: Drossman, D.A., ed. Rome III: The Functional Gastrointestinal Disorders. 3rd ed. McLean, VA: Degnon Associates, Inc. 2006. pp. 419-486.

This chapter on functional gastroduodenal disorders is from a lengthy reference book that presents the Rome III criteria for functional gastrointestinal disorders (FGIDs), a classification system based on the assumption and premise that for each disorder there are identifiable symptom clusters that emerge across clinical and population groups. The authors of this chapter use a classification that separates functional gastroduodenal disorders into functional dyspepsia, belching disorders, functional nausea and vomiting disorders, and the rumination syndrome. In each of these categories, the authors provide a definition and discuss epidemiology, symptoms, nomenclature and classification, clinical evaluation, physiological features, and treatment strategies. Specific topics include heartburn, the overlap of dyspepsia with gastroesophageal reflux disease and irritable bowel syndrome (IBS), gastrointestinal dysmotility, hypersensitivity, drug therapy, aerophagia, chronic idiopathic nausea, functional vomiting, and cyclic vomiting syndrome. The chapter concludes with a list of recommendations for future research in functional esophageal disorders. 8 figures. 4 tables. 305 references.

Full Record   Printer Friendly Version

Masqueraders of GERD. Flourtown, PA: Children's Digestive Health and Nutrition Foundation. 2005. 2 p.

Gastroesophageal reflux disease (GERD) is common in children and may be incompletely responsive to standard medical therapy. This fact sheet helps primary care providers consider other diagnoses that may be responsible for the patient’s symptoms. The author notes that clinical experience and the use of endoscopy have identified a number of different diseases presenting with symptoms formerly thought to be under the scope of GERD. The fact sheet discusses five of these conditions: eosinophilic esophagitis, food allergy, achalasia, cyclic vomiting syndrome, and rumination syndrome. For each, the fact sheet briefly outlines a definition, clinical features, diagnosis, treatment, and prognosis. The author concludes that it is important to be aware of these other diagnoses in order to provide the treatment that has the highest likelihood of success for the patient.

Full Record   Printer Friendly Version

Displaying all search results.

Start a new search.